Role of carcinoembryonic antigen, magnetic resonance imaging, and positron emission tomography-computed tomography in the evaluation of patients with suspected local recurrence of colorectal cancer

Clinical Imaging

Volumn 35, Issue 4, 2011, Pages 266-273

  Fiocchi, Federica ^a   Iotti, Valentina ^a   Ligabue, Guido ^a   Malavasi, Norma ^a   Luppi, Gabriele ^a   Bagni, Bruno ^a   Torricelli, Pietro ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

CEA; Colorectal cancer; Local recurrence; MRI; PET CT

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CEA; COLORECTAL CANCER; COMPUTED TOMOGRAPHY; DIAGNOSTIC PROTOCOLS; LOCAL RECURRENCE; NEGATIVE PREDICTIVE VALUE; PET-CT; POSITRON EMISSION;

ANTIGENS; COMPUTERIZED TOMOGRAPHY; DISEASES; MAGNETIC RESONANCE IMAGING; POSITRONS; RESONANCE;

POSITRON EMISSION TOMOGRAPHY;

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER RELAPSE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GOLD STANDARD; GRANULATION TISSUE; HISTOPATHOLOGY; HUMAN; INFLAMMATORY INFILTRATE; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; REOPERATION; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLONOSCOPY; COLORECTAL NEOPLASMS; CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; HETEROCYCLIC COMPOUNDS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IOPAMIDOL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 79959845732     PISSN: 08997071     EISSN: 18734499     Source Type: Journal    
DOI: 10.1016/j.clinimag.2010.07.010     Document Type: Article

References (29)

1. Schaefer O, Langer M Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol 2007, 17(8):2044-2054.
2. Torricelli P, Pecchi A, Luppi G, Romagnoli R Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer. Abdom Imaging 2003, 28(1):19-27.
3. Giordano P, Efron J, Vernava AM, Weiss EG, Nogueras JJ, Wexner SD Strategies of follow-up for colorectal cancer: a survey of the American Society of Colon and Rectal Surgeons. Tech Coloproctol 2006, 10(3):199-207.
4. Abir F, Alva S, Longo WE, Audiso R, Virgo KS, Johnson FE The postoperative surveillance of patients with colon cancer and rectal cancer. Am J Surg 2006, 192(1):100-108.
5. Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, Zuraw L, Zwaal C; Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care: Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003; 6; 3:26.
6. Jeffery GM, Hickey BE, Hider P Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2002, (1):CD002200.
7. Longo WE, Johnson FE The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg Clin North Am 2002, 82(5):1091-1108.
8. Arriola E, Navarro M, Pares D, Muñoz M, Pareja L, Figueras J, Soler G, Martinez M, Majem M, Germa-Lluch JR Imaging techniques contribute to increased surgical rescue of relapse in the follow-up of colorectal cancer. Dis Colon Rectum 2006, 49(4):478-484.
9. Desch CE, Benson AB, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Pfister DG, Virgo KS, Petrelli NJ Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005, 23(33):8512-8519. American Society of Clinical Oncology.
10. Chau I, Allen M, Cunningham D, Norman AR, Brown G, Ford HE, Tebbutt N, Tait D, Hill M, Ross PJ, Oates J The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol 2004, 22(8):1420-1429.
11. Renahan AG, Egger M, Saunders MP, O'Dwyer ST Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials. BMJ 2002, 324(7341):813.
12. Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema JD, van de Velde CJ Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 1994, 219(2):174-182.
13. Hara M, Kanemitsu Y, Hirai T, Komori K, Kato T Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study. Dis Colon Rectum 2008, 51(11):1675-1680.
14. Asoglu O, Karanlik H, Muslumanoglu M, Igci A, Emek E, Ozmen V, Kecer M, Parlak M, Kapran Y Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol 2007, 33(10):1199-1206.
15. Szynglarewicz B, Matkowski R, Forgacz J, Pudelko M, Smorag Z, Dryl J, Kornafel J Clinical factors in prediction of prognosis after anterior resection with total mesorectal excision for carcinoma of the rectum. Oncol Rep 2007, 17(2):471-475.
16. Kanellos I, Zacharakis E, Demetriades H, Christoforidis E, Kanellos D, Pramateftakis MG, Betsis D Value of carcinoembryonic antigen assay in predicting hepatic metastases, local recurrence, and survival after curative resection of colorectal cancer. Surg Today 2006, 36(10):879-884.
17. Duffy MJ Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?. Clin Chem 2001, 47(4):624-630.
18. Tan E, Gouvas N, Nicholls RJ, Ziprin P, Xynos E, Tekkis PP Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Surg Oncol 2009, 18(1):15-24.
19. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993, 270(8):943-947.
20. Fiocchi F, Iotti V, Ligabue G, Pecchi A, Luppi G, Bagni B, Rivasi F, Torricelli P Contrast enhanced MRI and PET-CT in the evaluation of patients with suspected local recurrence of rectal carcinoma. Radiol Med 2010, Jun 23. [Epub ahead of print].
21. Grossmann I, de Bock GH, Meershoek-Klein Kranenbarg WM, van de Velde CJ, Wiggers T Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial. Eur J Surg Oncol 2007, 33(2):183-187.
22. Bellomi M, Rizzo S, Travaini LL, Bazzi L, Trifirò G, Zampino MG, Radice D, Paganelli G Role of multidetector CT and FDG-PET/CT in the diagnosis of local and distant recurrence of resected rectal cancer. Radiol Med 2007, 112(5):681-690.
23. Barillari P, Bolognese A, Chirletti P, Cardi M, Sammartino P, Stipa V Role of CEA, TPA, and Ca 19-9 in the early detection of localized and diffuse recurrent rectal cancer. Dis Colon Rectum 1992, 35:471-476.
24. Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, Laurie JA Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998, 129:27-35.
25. Wichmann MW, Müller C, Lau-Werner U, Strauss T, Lang RA, Hornung HM, Stieber P, Schildberg FW The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer. Langenbecks Arch Surg 2000, 385(4):271-275.
26. Graham RA, Wang S, Catalano PJ, Haller DG Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Ann Surg 1998, 228(1):59-63.
27. Bleeker WA, Mulder NH, Hermans J, Otter R, Plukker JT Value and cost of follow-up after adjuvant treatment of patients with Dukes' C colonic cancer. Br J Surg 2001, 88(1):101-106.
28. Körner H, Söreide K, Stokkeland PJ, Söreide JA Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis. Ann Surg Oncol 2007, 14(2):417-423.
29. Renahan AG, Egger M, Saunders MP, O'Dwyer ST Mechanism of improved survival from intensive follow-up in colorectal cancer: a hypothesis. Br J Cancer 2005, 92.